Student's determination pays off as he achieves his ambition on graduation day
Talha Sufi completed three undergraduate and postgraduate courses to realise his ambition of becoming a medic.
The 29-year-old began his University of Central Lancashire journey by enrolling on the three-year BSc (Hons) Biomedical Science programme.
Following this, he signed up for a two-year physician associate postgraduate course.
He kept pushing forward and finally landed a hard-earned place on the competitive five-year Medicine and Surgery (MBBS) course.
READ MORE: Bolton medical student awarded scholarship at UCLan
UCLan graduation ceremony for Bolton mum and daughter
Ramsbottom's Victoria Derbyshire to receive honorary award at UCLan
Talha said: 'From the very start, my goal was clear - I wanted to become a doctor. Instead of taking the traditional route, I built my path in stages and that has meant spending 10 years at university and completing an undergraduate degree, a postgraduate diploma and now finally medical school.
'I feel excited that I've finally got to this moment as working as a doctor to serve my community is something I've wanting to do from an early age.'
It has been a balancing act for the former Darul Uloom Al Arabiya Al Islamiya School and Bury College pupil.
'Juggling the demands of work, family and study was hard while being a mature student,' commented Talha, from Bolton, "I had to find the balance so I could study, work part-time as a physician associate at a GP surgery in Deepdale, undertake placements at Royal Blackburn Teaching Hospital and find time for my family. However, with my family support my whole journey was made possible.'
Talha, who wants to specialise in general practice, has now moved to Dewsbury and is completing his mandatory two-year junior doctor programme at Leeds Teaching Hospitals NHS Trust.
He said: 'The university provided useful links and exposure to a variety of health sectors such as GP placements, surgical and medical rotations and first-hand teaching from hospital consultants and I'm looking forward to taking all this knowledge into my career.
'In the coming years I want to build my own surgery to serve my local community and really improve the health of those who are in need of health services. I want to have a wider impact on health improvement and the provision of social services for those who are struggling. Access to healthcare is a huge challenge for the elderly and those from ethnic minority backgrounds. I aim to bridge this gap and provide health services with care and compassion.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Man's Deadly Brain Tumor Vanishes After Taking Breakthrough Drug: ‘Lucky Break in a Devastating Situation'
A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared thanks to a breakthrough drug. In October 2022, Ben Trotman was 40 years old when he was diagnosed with glioblastoma, a rare form of terminal cancer that kills more than 10,000 Americans a year, according to the National Brain Tumor Society. Glioblastoma, also known as GBM, has no known cure. Standard treatment involves surgery to remove the tumor (if possible), followed by radiation and chemotherapy. The disease is considered a highly invasive tumor in the central nervous system because its cells reproduce extremely quickly. Those who are diagnosed with the malignant tumor have a median survival rate of about 14 to 14.5 months. Following his diagnosis, Trotman was referred by a friend to The National Hospital for Neurology and Neurosurgery at University College London Hospitals (UCLH). There, Dr. Paul Mulholland, a consultant medical oncologist, recruited Trotman to be the first patient in his clinical trial. The trial involved him receiving the immunotherapy drug ipilimumab to treat his glioblastoma before undergoing any standard treatment. Afterward, Trotman began radiation and chemotherapy. 'The crucial element of this trial is that patients will have their immune system boosted by the drug before they have any other treatment, when they are fit and well enough to tolerate the immunotherapy,' Mulholland said in a press release. The PEOPLE Puzzler crossword is here! How quickly can you solve it? Play now! Two years and eight months after being the sole participant in the clinical trial, Trotman, now 43, is tumor-free, and his scans have come back clear. 'It is very unusual to have a clear scan with glioblastoma, especially when he didn't have the follow-up surgery that had been planned to remove all of the tumour that was initially visible on scans,' Mulholland explained. 'We hope that the immunotherapy and follow-up treatment Ben has had will hold his tumour at bay, and it has so far, which we are delighted to see.' Mulholland added that his goal is to find a cure for the 'devastating disease' that is glioblastoma, and he's hoping to move forward with additional patients. Trotman is now married to wife Emily, and the couple welcomed daughter Mabel in April. The couple told the hospital that the clinical trial gave Trotman his life back. 'Getting this diagnosis was the most traumatic experience,' Emily said. 'We were grappling with the fact that Ben had gone from being apparently perfectly healthy to having months to live. Had we not met Dr. Mulholland, that would have been it for us. We felt we had a lucky break in an otherwise devastating situation.' 'We obviously don't know what the future holds, but having had the immunotherapy treatment and getting these encouraging scan results has given Emily and I a bit of hope,' Trotman added. 'We are focused on rebuilding the life we thought we had lost and enjoying being parents.' The new father said he's hoping that his brain cancer journey will give others hope and inspire more patients to participate in the next clinical trial. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. is now available in the Apple App Store! Download it now for the most binge-worthy celeb content, exclusive video clips, astrology updates and more! Dame Siobhain McDonagh — member of parliament of the UK who lost her sister from glioblastoma in 2023 — led a fundraising campaign and raised more than €1 million to cover the costs of the next trial. 'My beloved sister Margaret was appalled to discover that there had been no advances in brain cancer treatment for decades when she was diagnosed with glioblastoma,' McDonagh said. 'Changing this was Margaret's final campaign and one that I have continued in her memory. I am so grateful to the many people who knew and respected Margaret who have come together and helped to raise funds and campaign for this new trial that we are calling Margaret's Trial.' Mullholland recalled meeting Margaret. 'When I met Margaret, she said to me, 'What can I do to support you to cure this disease?'" 'I am incredibly grateful to her and to Siobhain, whose campaigning and fundraising in her sister's memory has led to this new clinical trial opening for patients with this most aggressive form of brain cancer that has such a poor prognosis.' Read the original article on People
Yahoo
6 hours ago
- Yahoo
Disabled could be helped back into work with new right similar to maternity law
People with disabilities could be helped back into work with similar protections as those for women returning from maternity leave, a new report has suggested. A new right to reintegration for workers on sick leave could see firms prevented from dismissing someone unless it is shown the employer has made sufficient efforts at reintegrating the person, the Resolution Foundation think tank said. They said such a right would 'would clarify and strengthen existing legal protections' under the the Equality Act and 'provide a much stronger message to workers about what they are entitled to'. The report warned that the Government risks failing to meet its aim to raise the employment rate to 80% without a 'serious strategy to shift employer behaviour' and argues employers must be incentivised to reintegrate existing workers back into jobs. The report comes in the same week as the Universal Credit Bill cleared the House of Lords, aimed at rebalancing the benefit 'to remove work disincentives', according to a Government minister, while giving existing claimants 'the security and certainty they need'. Separately during the debate, Paralympic champion Baroness Tanni Grey-Thompson, who sits in the Lords, said disabled people have been portrayed as 'benefit scroungers and a drain on society' in the conversation on welfare reform. In its report, the Resolution Foundation said around 12% of disabled staff leave work each year – consistently 1.5-times the rate of non-disabled workers. It added that twice as many people move from work into inactivity due to ill health – around 304,000 each year – than those moving the other way (around 151,000). But the think tank said despite there being 'strong' legal obligations in place already on employers, they are 'simply not doing enough to retain existing workers', with fewer than half of disabled workers who request a reasonable adjustment – which can include a change to working arrangements or provision of equipment, services or support – having this granted in full. With 15% of disabled people reporting workplace discrimination relating to their disability in 2022, the report said this remains a 'pressing issue'. The think tank said: 'Boosting disability employment is not straightforward: it will involve improvements to the health system, benefits system and world of work. But action to incentivise and support employers is a vital piece of the puzzle.' Louise Murphy, senior economist at the Resolution Foundation, said: 'The Government should do more to incentivise firms to employ disabled people – especially those who have been out of work for long periods – but employers need to do more in return. 'A new right to reintegration could help disabled workers back into work in the same way that maternity rights transformed women's employment prospects a generation ago.' The foundation said the new right could be enforced through employment tribunals, but urged the Government to also consider 'more proactive enforcement mechanisms, whether via the Equalities and Human Rights Commission or connected to a new system of caseworkers that are expected to be covered in the forthcoming Mayfield Review'. Former John Lewis boss, Sir Charlie Mayfield, is undertaking a review to investigate how Government and businesses can work together to support ill and disabled people into work, with a report expected in autumn. The Government has been contacted for comment.
Yahoo
6 hours ago
- Yahoo
Up to 85,000 women may have had postnatal depression last year, analysis finds
Up to 85,000 new mothers in England may have been impacted by postnatal depression last year, according to new analysis. The illness can be 'truly devastating' when left untreated, potentially leading to the 'unnecessary' deaths of women and sometimes their babies, the Royal College of Psychiatrists (RCPsych) warned. Postnatal depression is a condition that can develop after childbirth. While many women may feel tearful or anxious after giving birth, this does not usually last for more than two weeks. Persistent feelings of sadness, low mood, a lack of interest in things and a lack of energy could indicate postnatal depression. Other symptoms can include trouble sleeping, withdrawing from other people, problems concentrating and scary thoughts, such as thinking about hurting your baby. Using Office for National Statistics data which shows there were 567,708 live births in 2024, RCPsych estimates between 56,000 to 85,000 mothers – or between 10% to 15% – may have experienced postnatal depression. The college highlights that maternal suicide is the leading cause of death in women from six weeks to a year after birth and also said prenatal mental illness – conditions that develop during pregnancy – can put unborn babies at risk of premature birth or low birth weight. RCPsych is urging women and their partners to seek support for these treatable conditions. Dr Trudi Seneviratne, consultant perinatal psychiatrist and immediate past RCPsych registrar, said: 'Women can experience an enormous amount of change, including increased stress factors when they become pregnant, and this may negatively affect their mental health. 'Postnatal depression is far more common than many people realise and can have a devastating impact on mothers, babies and families if left untreated.' Treatment for postnatal depression can include talking therapies or antidepressants. Dr Seneviratne stressed that medics are trained to ensure medication is safe to take when pregnant or breastfeeding, and warned that the risks of untreated depression outweigh the risk of antidepressants. 'Mothers who receive talking therapy and other forms of care from mental health services will often be able to recover, but some might be so unwell that they need medication, including antidepressants,' she said. 'Medication helps save lives. The dangers of untreated depression far outweigh the risks of antidepressants. 'The unnecessary deaths of mothers and sometimes their babies that result from failure to treat these conditions are truly devastating. 'Doctors are trained to ensure that the medication they prescribe is as safe as possible to take while pregnant or breastfeeding. Medication should be reviewed regularly, and any side effects closely monitored. 'For children to thrive, they need as good a start in life as possible, and this is important not only for the child and their mother but also communities and society as well. We all have a role to play in ensuring mothers and their partners feel confident seeking support when they need it.'
